he Apotex legal team has seen a lot of action lately as the company is embroiled in two major lawsuits.

Apotex is contesting the patent on blood thinner Plavix, arguing it should be allowed to distribute a generic version.

The company managed to ship six months’ worth of the drug before a U.S. judge ordered it to cease shipments in August.

In the second lawsuit, Apotex is suing U.S. regulators to prevent rivals from gaining rights to nausea drug Zofran.

"When we strengthen our publics, we strengthen ourselves. Truly,
all are strengthened."
- Bernard Sherman